About
PEG Religrast 6mg Injection contains the active ingredient Pegfilgrastim, a granulocyte colony-stimulating factor (G-CSF) approved by the FDA. It is used to reduce the risk and duration of febrile neutropenia (fever or infection with low white blood cell count) in patients receiving bone marrow–suppressive chemotherapy. It also helps improve survival in patients exposed to radiation therapy that causes severe, life-threatening bone marrow damage. Pegfilgrastim works by stimulating the multiplication and activation of blood-forming cells.
Pegfilgrastim is a protein produced using biotechnology in E. coli bacteria. It belongs to the cytokine family and closely resembles the natural protein G-CSF made by the body, which supports white blood cell (WBC) production. Since chemotherapy often lowers WBC counts, this medicine helps reduce infection risk by restoring adequate levels.
Before starting treatment, inform your doctor if you have liver disease, kidney problems, heart disorders, fever, infection, or a family history of kidney disease. Do not take this injection if you are allergic to Pegfilgrastim or any of its ingredients. Seek medical attention immediately if you experience left upper abdominal pain, shoulder pain, or breathing difficulties. The most common side effects include pain in the bones, arms, and legs.
Uses
- Decrease the chance of infection caused by low levels of white blood cells in patients with certain types of cancer (non-myeloid) receiving bonemarrow suppressing anti-cancer drugs.
- To increase the survival rate in patients receiving radiation therapy that suppresses bone marrow activity.
Directions for use
This medicine will be administered by your doctor or nurse. Please do not attempt to self-administer it.
Side effects
Serious :
- Pain in the bones, joints and muscles
- Pain at the site of Injection
- Itchiness and skin rash
- Nausea
- Headaches
- Dizziness and tiredness
Common:
- Inflammation of Aorta
- Capillary leak syndrome (plasma leaks out of tiny blood vessels)
- Hypersensitivity reactions
- Changes in urine color
- Swelling in hands, feet, face, and abdomen
- Difficulty in breathing
- Sickle cell anemia
Safety Measures
Alcohol - Alcohol consumption is unsafe with PEG Religrast 6mg Injection. Consult your doctor for further guidance.
Pregnancy - PEG Religrast 6mg Injection is unsafe during pregnancy as it may cause birth defects. Inform your doctor if you are pregnant or planning pregnancy before starting treatment.
Breastfeeding - It is unsafe to breastfeed during the treatment with this PEG Religrast 6mg Injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.
Liver - It is unknown whether PEG Religrast 6mg Injection can be administered in patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this Injection.
Kidney - Peg-ReliGrast Injection is generally safe for patients with kidney disease, and no dose adjustment is required.
Disclaimer
Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!